Artemis Medicare Services Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026 (Q4FY26), pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 162A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report, prepared by CARE Ratings Limited in its capacity as Monitoring Agency, pertains to the utilization of proceeds from the company's Preferential Issue of Compulsorily Convertible Debentures aggregating to Rs. 330.00 crore. The Audit Committee reviewed the report at its meeting held on May 8, 2026.

Issue and Issuer Details

The Preferential Issue was undertaken by Artemis Medicare Services Limited, a company operating in the Healthcare Services – Hospital sector. The promoters are Mr. Onkar Kanwar and Constructive Finance Private Limited. The key details of the issue are summarized below:

Utilization of Issue Proceeds

During Q4FY26, the company utilized Rs. 74.62 crore towards supporting acquisition, expansion, and capital expenditure requirements. Specifically, the company signed a Medical Service Agreement (MSA) with Dr Vidyasagar Kaushalya Devi Memorial Health Centre and paid an additional advance revenue share of Rs. 74.62 crore as per the terms of the MSA. No amount was utilized towards General Corporate Purposes during the quarter. The following table captures the progress in utilization of the issue proceeds:

Deployment of Unutilized Proceeds

The total unutilized amount of Rs. 193.11 crore as at the end of the quarter has been deployed across fixed deposits with multiple banks. The company also received interest of Rs. 0.05 crore on matured Fixed Deposits, which has been reinvested in Fixed Deposits. The details of the deployment are as follows:

Compliance and Deviation Status

The Monitoring Agency confirmed that all utilization is in accordance with the disclosures in the Offer Document, with no deviations observed from earlier monitoring agency reports. The means of finance for the disclosed objects have not changed. No favorable or unfavorable events affecting the viability of the objects were reported, and no other material information affecting investor decision-making was identified. Both objects of the issue — acquisition, expansion, and capital expenditure requirements, as well as General Corporate Purposes — are listed as ongoing, with a completion date of May 15, 2026 as per the Offer Document, and no delay in days or months has been reported.

The Chartered Accountant's certificate relied upon for this report was issued by M/s T R Chadha & Co. LLP, Statutory Auditors of Artemis Medicare Services Limited, dated April 30, 2026. The report notes that the CA certificate provides limited assurance, and the procedures performed are less in extent than those for a reasonable assurance engagement.

Artemis medicare services Limited has submitted its mandatory compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The healthcare services company filed the certificate with both the National Stock Exchange of India Limited and BSE Limited on April 6, 2026.

Regulatory Filing Details

The compliance certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Poonam Makkar signed the filing on behalf of Artemis Medicare Services Limited.

Registrar Confirmation

Alankit Assignments Limited, serving as the registrar and transfer agent, provided the compliance certificate confirming proper handling of dematerialization processes. Kamal Garg, General Manager at Alankit Assignments Limited, digitally signed the certificate on April 6, 2026.

The registrar confirmed that securities comprised in physical share certificates received for dematerialization have been properly processed. The certificate states that after due verification, physical certificates were mutilated and cancelled, with the depository name being substituted in records as the registered owner.

Compliance Framework

The filing demonstrates Artemis Medicare Services Limited's adherence to SEBI's regulatory framework governing depositories and participants. The quarterly compliance certificate ensures transparency in the dematerialization process and maintains investor confidence in the electronic settlement system.

Alankit Assignments Limited holds multiple SEBI registrations and operates from its registered office in New Delhi, providing comprehensive registrar and transfer agent services to listed companies.